ACUT — Accustem Sciences Inc.

—
OTC · Health Care · Pharmaceuticals · CIK 1850767 ·
Last close
$0.12
Market Cap
$1.90M
52W High
$1.00
52W Low
$0.12
ADV30
1,404
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -350,973 -252,573 1,606,204 12,928 5,723,821
Mar 2026 0 — -485,883 -485,883 1,549,532 12,207 5,421,879
Dec 2025 0 — -514,388 -514,388 1,549,446 13,929 4,951,071
Sep 2025 0 — -399,897 -399,897 1,573,247 14,391 4,484,157

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-1,204,800
Investing CF
—
Financing CF
$1,186,386
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.09
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-10,521,599
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-1,751,141
Pretax Income TTM
$-1,652,741
Interest Exp TTM
—
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$98,400
EBITDA
$-1,652,532
Free Cash Flow
$2,105,159
Enterprise Value
$2,492,697
Total Cash
$12,928
Total Debt
$62,641
Shares Out
16,072,267
Trailing EPS
$-0.11
Book Value
$-0.26
ROE
—
ROA
-64.2%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -1,756,096 -1,756,096 1,549,446 4,951,071 -3,401,625 -850,389
Dec 2024 0 -1,505,102 -1,505,102 50,851 3,364,075 -3,313,224 -664,066
Dec 2023 0 -2,050,664 -2,050,664 133,897 2,245,477 -2,111,580 -1,615,643
Dec 2022 0 -3,746,419 -3,746,419 939,689 1,079,239 -139,550 -1,806,053

TTM Snapshot

Revenues TTM
$98,400
NetIncome TTM
$-1,652,741
OpCashFlow TTM
—
Assets (Latest)
$1,606,204
Forward EPS
—

Peers — same industry

TickerNameMarket CapLastDaily %
SXTP 60 DEGREES PHARMACEUTICALS, INC. $1.88M $0.53 —
XRTX XORTX Therapeutics Inc. $1.93M $1.06 —
PPCB Propanc Biopharma, Inc. $1.94M $1.88 —
JAGX Jaguar Health, Inc. $1.96M $0.38 —
JUNS JUPITER NEUROSCIENCES, INC. $2.00M $1.52 —

News headlines (Yahoo Finance, 1h cache)

AccuStem Sciences Announces StemPrintER Pilot Study with National Surgical Adjuvant Breast and Bowel Project (NSABP)
2026-01-08 12:00 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.